"It's Russian roulette": adulteration, adverse effects and drug use transitions during the 2010/2011 United Kingdom heroin shortage - PubMed (original) (raw)
"It's Russian roulette": adulteration, adverse effects and drug use transitions during the 2010/2011 United Kingdom heroin shortage
Magdalena Harris et al. Int J Drug Policy. 2015 Jan.
Abstract
Background: Between late 2010 and mid 2011 there was a significant heroin shortage in the United Kingdom (UK), resulting in a rapid drop in street heroin purity and increase in price. The most well documented event of this kind is the 2000-2001 Australian heroin shortage, with little published research addressing the UK context. In this paper we draw on qualitative data to explore the impact of, and responses to, the 2010/2011 shortage among London-based heroin users.
Methods: Data collection comprised longitudinal life history and narrative interviews with 37 PWID in 2010-2011. The average age of participants was 40, with a 20-year average duration of injecting. Heroin was the drug of choice for the majority of participants (25), with 12 preferring to inject a crack-cocaine and heroin mix. Recruitment took place through London drug and alcohol services and peer networks.
Results: The majority of participants continued to source and inject heroin despite reported decline in purity and increased adulteration. Transitions to poly-drug use during the heroin shortage were also common, increasing vulnerability to overdose and other drug related harms. Participants enacted indigenous harm reduction strategies in attempting to manage changes in drug purity and availability, with variable success.
Conclusion: Epidemiological data gathered during periods of heroin shortage is often drawn on to emphasise the health benefits of reductions in supply. Our findings highlight the importance of understanding the ways in which heroin shortages may increase, as well as reduce, harm. There is a need for enhanced service provision during periods of drug shortage as well as caution in regard to the posited benefits of supply-side drug law enforcement.
Keywords: Adulteration; Drug market; Harm reduction; Heroin; Qualitative; United Kingdom.
Copyright © 2014 Elsevier B.V. All rights reserved.
Similar articles
- Injecting-related health harms and overuse of acidifiers among people who inject heroin and crack cocaine in London: a mixed-methods study.
Harris M, Scott J, Wright T, Brathwaite R, Ciccarone D, Hope V. Harris M, et al. Harm Reduct J. 2019 Nov 13;16(1):60. doi: 10.1186/s12954-019-0330-6. Harm Reduct J. 2019. PMID: 31722732 Free PMC article. - Effects of a sustained heroin shortage in three Australian States.
Degenhardt L, Day C, Dietze P, Pointer S, Conroy E, Collins L, Hall W. Degenhardt L, et al. Addiction. 2005 Jul;100(7):908-20. doi: 10.1111/j.1360-0443.2005.01094.x. Addiction. 2005. PMID: 15954999 - A qualitative analysis of transitions to heroin injection in Kenya: implications for HIV prevention and harm reduction.
Guise A, Dimova M, Ndimbii J, Clark P, Rhodes T. Guise A, et al. Harm Reduct J. 2015 Sep 4;12:27. doi: 10.1186/s12954-015-0061-2. Harm Reduct J. 2015. PMID: 26337729 Free PMC article. - Evaluating explanations of the Australian 'heroin shortage'.
Degenhardt L, Reuter P, Collins L, Hall W. Degenhardt L, et al. Addiction. 2005 Apr;100(4):459-69. doi: 10.1111/j.1360-0443.2005.01000.x. Addiction. 2005. PMID: 15784060 Review. - [Chief health risks associated with intravenous heroin and cocaine abuse].
Ben Diane MK, Feroni I, Poncet M, Obadia Y. Ben Diane MK, et al. Presse Med. 2000 Mar 4;29(8):453-7. Presse Med. 2000. PMID: 10738515 Review. French.
Cited by
- Analysis of the UK Government's 10-Year Drugs Strategy-a resource for practitioners and policymakers.
Holland A, Stevens A, Harris M, Lewer D, Sumnall H, Stewart D, Gilvarry E, Wiseman A, Howkins J, McManus J, Shorter GW, Nicholls J, Scott J, Thomas K, Reid L, Day E, Horsley J, Measham F, Rae M, Fenton K, Hickman M. Holland A, et al. J Public Health (Oxf). 2023 Jun 14;45(2):e215-e224. doi: 10.1093/pubmed/fdac114. J Public Health (Oxf). 2023. PMID: 36309802 Free PMC article. - Sold as Heroin: Perceptions and Use of an Evolving Drug in Baltimore, MD.
Mars SG, Ondocsin J, Ciccarone D. Mars SG, et al. J Psychoactive Drugs. 2018 Apr-Jun;50(2):167-176. doi: 10.1080/02791072.2017.1394508. Epub 2017 Dec 6. J Psychoactive Drugs. 2018. PMID: 29211971 Free PMC article. - Shifts in substance use patterns among a cohort of people who use opioids after delisting of OxyContin in BC, Canada: An interrupted time series study.
Karamouzian M, Buxton JA, Hategeka C, Nosova E, Hayashi K, Milloy MJ, Kerr T. Karamouzian M, et al. Int J Drug Policy. 2022 Nov;109:103852. doi: 10.1016/j.drugpo.2022.103852. Epub 2022 Sep 16. Int J Drug Policy. 2022. PMID: 36122483 Free PMC article. - An ethnographic exploration of drug markets in Kisumu, Kenya.
Syvertsen JL, Ohaga S, Agot K, Dimova M, Guise A, Rhodes T, Wagner KD. Syvertsen JL, et al. Int J Drug Policy. 2016 Apr;30:82-90. doi: 10.1016/j.drugpo.2016.01.001. Epub 2016 Jan 8. Int J Drug Policy. 2016. PMID: 26838470 Free PMC article. - A rapid review of the impacts of "Big Events " on risks, harms, and service delivery among people who use drugs: Implications for responding to COVID-19.
Zolopa C, Hoj S, Bruneau J, Meeson JS, Minoyan N, Raynault MF, Makarenko I, Larney S. Zolopa C, et al. Int J Drug Policy. 2021 Jun;92:103127. doi: 10.1016/j.drugpo.2021.103127. Epub 2021 Jan 20. Int J Drug Policy. 2021. PMID: 33549464 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical